scispace - formally typeset
R

Ronald Schoenmakers

Researcher at École Polytechnique Fédérale de Lausanne

Publications -  9
Citations -  831

Ronald Schoenmakers is an academic researcher from École Polytechnique Fédérale de Lausanne. The author has contributed to research in topics: Transgene & Self-healing hydrogels. The author has an hindex of 8, co-authored 9 publications receiving 801 citations. Previous affiliations of Ronald Schoenmakers include University of Zurich.

Papers
More filters
Journal ArticleDOI

Three-dimensional extracellular matrix-directed cardioprogenitor differentiation: Systematic modulation of a synthetic cell-responsive PEG-hydrogel

TL;DR: It is shown that synthetic three-dimensional matrix metalloproteinase (MMP)-sensitive poly(ethylene glycol) (PEG)-based hydrogels can direct differentiation of pluripotent cardioprogenitors, using P19 embryonal carcinoma (EC) cells as a model, along a cardiac lineage in vitro.
Journal ArticleDOI

Biomolecular hydrogels formed and degraded via site-specific enzymatic reactions.

TL;DR: In this article, the design of oligopeptide building blocks with dual enzymatic responsiveness allows to create polymer networks that are formed and functionalized via enzymes and are degradable via other enzymes, both occurring under physiological conditions.
Patent

Biomaterials formed by nucleophilic addition reaction to conjugated unsaturated groups

TL;DR: This paper used nucleophilic addition reactions to conjugated unsaturated groups to create polymeric biomaterials formed by nucleophilicity of nucleophiles for medical treatments, which can be used for medical applications.
Patent

Conjugate addition reactions for the controlled delivery of pharmaceutical active compounds

TL;DR: This article used nucleophilic addition reactions to conjugated unsaturated groups to create polymeric biomaterials formed by nucleophilicity of nucleophiles for medical treatments, which can be used for medical applications.
Journal ArticleDOI

Engineered Streptomyces quorum-sensing components enable inducible siRNA-mediated translation control in mammalian cells and adjustable transcription control in mice.

TL;DR: Recent advances in functional genomics, gene therapy, tissue engineering, drug discovery and biopharmaceuticals production have been fostered by precise small‐molecule‐mediated fine‐tuning of desired transgenes.